Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Top tierCronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS®, LIT™, and Lord Jones®.
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Business segments
Q2 2026 · $53.0MThe company’s own SEC segment disclosure.
- Canada$28.7M54%
- Israel$15.0M28%
- Other Countries$9.3M18%
Cronos Group Inc. (CRON) reported revenue of $45M in Q1 2026 (quarter ended March 31, 2026), up 40% from the same quarter a year earlier. That came with a gross margin of 42% and net income of $14M (30% of revenue). For the full year FY2025, revenue was $147M (+25% year on year) and net income −$9.4M. Its largest region in 2026-Q2 was Canada at $29M, 54% of the disclosed total, just ahead of Israel at 28%.
Raw charts
10 series · TTMAs reported to the SEC, without any scoring.
Drug Manufacturers - Specialty & Generic
Ranks #4 of 28 by Smart Score